## TDG: Transdigm Group Incorporated - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.9% below STRENGTH zone (3.0-6.0%); PEG 3.20 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1234.90)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Transdigm Group Incorporated $TDG is Hudson Way Capital Management LLC's 5th Largest Position**
- Source: MarketBeat | 20251214T130856 | Bullish | Relevance: 100%
- Hudson Way Capital Management LLC reduced its stake in Transdigm Group (TDG) by 7.6% in Q2, but it remains their fifth-largest holding, valued at approximately $96.63 million. Transdigm exceeded Q2 earnings and revenue expectations, and insiders have recently been net sellers of the stock. Analyst ratings for TDG are largely positive, with a consensus of "Moderate Buy."

**2. Holocene Advisors LP Acquires 22,390 Shares of Transdigm Group Incorporated $TDG**
- Source: MarketBeat | 20251214T125153 | Somewhat-Bullish | Relevance: 100%
- Holocene Advisors LP increased its holdings in Transdigm Group Incorporated ($TDG) by 18.7% in Q2, acquiring 22,390 additional shares to own a total of 142,043 shares valued at approximately $216 million. Despite this, company insiders have been net sellers, with significant share sales by Director Kevin M. Stein and COO Joel Reiss in recent months. Transdigm exceeded quarterly earnings expectations and maintains a "Moderate Buy" consensus rating with a $1,576.29 target price from analysts.

**3. Transdigm Group Incorporated $TDG Shares Purchased by George Kaiser Family Foundation**
- Source: MarketBeat | 20251213T114743 | Somewhat-Bullish | Relevance: 100%
- George Kaiser Family Foundation significantly increased its stake in Transdigm Group Incorporated (NYSE:TDG) by 1,515.8% in the second quarter, making it their 9th biggest position. Other institutional investors also adjusted their holdings in the aerospace company. Various Wall Street analysts have weighed in on TDG, with a consensus target price of $1,576.29, despite recent insider selling by company executives.

**4. Goodman Advisory Group LLC Invests $3 Million in Transdigm Group Incorporated $TDG**
- Source: MarketBeat | 20251214T092005 | Somewhat-Bullish | Relevance: 100%
- Goodman Advisory Group LLC has invested $3 million in Transdigm Group Incorporated, acquiring 1,973 shares in Q2. Despite significant insider selling totaling $199.3 million, institutional investors hold 95.78% of the stock, and analysts maintain a "Moderate Buy" rating with a $1,576.29 price target. The company recently surpassed quarterly EPS and revenue estimates and provided positive FY2026 guidance.

**5. Bamco Inc. NY Sells 20,000 Shares of Transdigm Group Incorporated $TDG**
- Source: MarketBeat | 20251213T100843 | Neutral | Relevance: 98%
- Bamco Inc. NY has reduced its stake in Transdigm Group Incorporated by 18.5%, selling 20,000 shares, now holding 87,844 shares valued at $133.58 million. Insider selling has also been significant, with COO Joel Reiss and Director Robert J. Small offloading shares worth $5.23 million and $121.49 million, respectively, in recent transactions. Despite these sales, Transdigm reported strong Q3 earnings, surpassing analyst estimates with EPS of $10.82 and 11.5% revenue growth, and analysts maintain a "Moderate Buy" rating with a consensus target price of $1,576.29.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 29 ($1.91M) |
| Sells | 12 ($106.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 61.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+1.8%)
- Capital Internationa: 11.5% (+4.1%)
- Blackrock Inc.: 7.4% (-1.6%)
- Capital World Invest: 7.0% (-0.8%)
- JPMORGAN CHASE & CO: 4.5% (+26.5%)

### Key Risks

1. Heavy insider selling: $107M sold (12 transactions in 90 days).
2. Valuation risk: PEG 3.2x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 6.6% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.20 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROA 11%, margin 24%). Balance sheet: strong liquidity (3.2x), $1.8B free cash flow. Insider selling cluster ($107.0M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $72.8B |
| Beta | 0.92 |
| 52W Range | $1183.60 - $1623.83 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.20 |
| Forward P/E | 28.3 |
| Current P/E | 33.7 |
| YoY Growth | 19.1% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -3.0% to -0.9% (+2.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.9pp (needs >3.0% for momentum thesis). MRS_5 turning positive (0.5%) - potential reversal signal. Underperforming sector by 3.6pp, stock-specific weakness. Below SMA200 (0.93x), long-term trend not supportive. MACD histogram bearish (-7.52), momentum weakening. RSI neutral at 40. OFD pattern: -SLH (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.87% (CS: 20) | Neutral |
| RSI_14 | 40.3 | Neutral |
| MACD Histogram | -7.52 | Bearish |
| vs SMA20 | 0.967x | Below |
| vs SMA50 | 0.983x | Below |
| vs SMA200 | 0.934x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1292.08
- **Stop Loss:** $1234.90 (4.4% risk)
- **Target:** $1349.26 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $25,841.60
- **Portfolio %:** 25.84%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at moderate levels (16.5) with elevated put/call ratio suggesting cautious positioning, while normal yield curve and stable breadth indicate no systemic stress. Focus on selective opportunities with defensive positioning.*

### Earnings

**Next:** 2026-02-03 (Est: $8.00)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.05 | $10.82 | +7.6% |
| 2025Q2 | $9.90 | $9.60 | -3.0% |
| 2025Q1 | $8.95 | $9.11 | +1.8% |
| 2024Q4 | $7.74 | $7.83 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*